Afatinib

CAS 439081-18-2

Also known as: BIBW2992

Afatinib is a potent and irreversible dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 tyrosine kinase. This product is suitable for the treatment of the following patients: 1. Local advanced or metastatic non-small cell lung cancer with EGFR receptor gene sensitive mutation, 2. Local advanced or metastatic squamous cell lung cancer without EGFR tyrosine kinase inhibitor treatment during or after chemotherapy with platinum.

Request a Quote
Category: Pharmaceutical Chemicals APISubcategory: Antineoplastic Drugs APIProduct ID: afatinib-439081-18-2
Payment & Shipping Terms Supply Capacity
Payment Terms: T/T, WU Production Capacity: 1000kg/year
Min. Order: 1 Gram Packing: according to the customer's requirements
Means of Transport: Ocean, Air, Land Delivery Date: 7 days

Afatinib

CAS 439081-18-2

Afatinib is a potent and irreversible dual inhibitor of epidermal growth factor receptor and human epidermal growth factor receptor 2 tyrosine kinase. This product is suitable for the treatment of the following patients: 1. Local advanced or metastatic non-small cell lung cancer with EGFR receptor gene sensitive mutation, 2. Local advanced or metastatic squamous cell lung cancer without EGFR tyrosine kinase inhibitor treatment during or after chemotherapy with platinum.

We can customize according to customer's requirement

if you have any question pls mail us or call us.

CAS Number 439081-18-2
Molecular Formula C24H25ClFN5O3
Molecular Weight 485.94
Place of Origin Shandong,China (Mainland)
Specification CP/USP/EP
Content 98%min
Density 1.381g/cm3
Flashing point 363.186°C
Request a quote

Send an inquiry for Afatinib

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

×
MOSINTER chemical operations

Request a Quote

By sending this inquiry, you acknowledge our Privacy Policy. We use these details only to answer your request.

We usually respond within one business day.

MOSINTER GROUP